MedPath

a cohort study of young female cancer survivors who received fertility-sparing treatment

Not Applicable
Recruiting
Conditions
Neoplasms
Registration Number
KCT0009578
Lead Sponsor
Koera University Guro Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
200
Inclusion Criteria

1)Women diagnosed with female cancer (ovarian cancer, uterine cancer, cervical cancer)
-Including ovarian borderline tumors, endometrial epithelium tumors
2)a woman under the age of 45
3)Cancer survivors who have received fertility preservation treatment and have been treated
4)Cancer Survivors More Than 3 Months After Diagnosis

Exclusion Criteria

1)No fertility preservation treatment
- Removal of uterus or removal of both ovaries due to surgery
-Early menopause due to anticancer or radiation therapy, loss of uterine function
2)Ovarian cancer, uterine cancer, cervical cancer and other female cancer
Q: Breast cancer
3)If you are diagnosed with ovarian cancer, uterine cancer, cervical cancer, and other carcinomas and require additional treatment
4)If you already have a diagnosed sexual dysfunction prior to cancer treatment

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Identifying the occurrence of sexual dysfunction and unmet needs after treatment in young female cancer survivors who received fertility preservation treatment
Secondary Outcome Measures
NameTimeMethod
Comparison of risk factors related to recurrence risk after fertility preservation treatment and effectiveness between fertility preservation treatments, identification of unmet needs. Confirmation of menopause, pregnancy, and fertility rates and identification of unmet needs after fertility preservation cancer treatment. Confirmation of deterioration of quality of life after childbearing preservation cancer treatment and identification of unmet needs
© Copyright 2025. All Rights Reserved by MedPath